Mr. Fernando Rodriguez
President and CEO
Prime Lab LLC
Sabanetas Industrial Park
Building M, Solar 18, Local 2
Ponce 00716
Puerto Rico
gpagan@primjanitorial.comFEI 3017199840Issued Jan 2, 2024Office of Pharmaceutical Quality
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3017199840.
Violations4
Issue DateJan 2, 2024
Product TypeDrugs
StatusOpen
Letter Details
Firm
Prime Lab LLC
Location
Mr. Fernando Rodriguez
President and CEO
Prime Lab LLC
Sabanetas Industrial Park
Building M, Solar 18, Local 2
Ponce 00716
Puerto Rico
gpagan@primjanitorial.com
FEI Number
3017199840
Country
Puerto Rico
Issue Date
January 02, 2024
Issuing Office
Office of Pharmaceutical Quality
Product Type
Drugs
Status
Open
Summary
Prime Lab LLC, a drug manufacturer in Puerto Rico, was cited for significant Current Good Manufacturing Practice (CGMP) violations in the production of over-the-counter antibacterial hand soap and hand sanitizer products. The company failed to adequately test incoming raw material components for identity, purity, strength, and quality, and instead relied on suppliers' certificates of analysis without validating the reliability of those suppliers' testing at appropriate intervals. These deficiencies rendered the finished drug products adulterated under federal law, as the firm could not provide scientific evidence that components conformed to appropriate specifications prior to manufacturing.